People

Overview

Christopher Wilson is a partner in Baker Botts' Antitrust and Competition Practice group. His practice focuses on civil antitrust and other complex commercial litigation. Mr. Wilson has extensive experience representing both defendants and plaintiffs in federal and state courts from complaint filing through trial, and regularly advises corporate clients on a variety of antitrust and compliance matters. He has represented and advised clients across a range of industries, including but not limited to industrial manufacturing, telecommunications, pharmaceuticals, retail, and healthcare manufacturing.

Chris leads legal teams for a number of Fortune 500 clients either asserting or defending against antitrust claims in some of the largest antitrust cases in the country. He also has extensive experience defending pharmaceutical companies in patent infringement and antitrust actions, as well as representing generic pharmaceutical manufacturers in Hatch-Waxman Act litigation.

Chris has served as co-chair of the American Bar Association Section of Litigation's Antitrust Litigation and Consumer Litigation Committees, and is a member of the ABA’s Antitrust Section as well as the Commercial Litigation Section of the National Bar Association. He currently serves as a member of the External Advisory Board for the Schreyer Honors College at Penn State University. He is also actively involved in community and charitable organizations; he is currently the legal advisor for a polo-centric nonprofit based in Washington, D.C., and previously served as the President of the "Make A Wish" Illinois Associate Board.

Chris graduated from Stanford Law School, where he served as President of the Stanford Black Law Students Association and as Treasurer for the Black Graduate Students Association; he also participated in legal clinics directed to criminal defense and public education law. He received his undergraduate degree from Penn State, where he was a Schreyer Honors Scholar and played running back and fullback for the university's football team.

Admissions & Affiliations

  • District of Columbia Bar
  • Illinois State Bar
  • United States Court of Appeals for the Third Circuit
  • United States District Court for the Northern District of Illinois

Education

  • J.D., Stanford Law School 2012
  • B.A., Political Science, Pennsylvania State University 2006
    with honors

Experience

  • In re: Pork Antitrust Litigation – Lead counsel for ALDI Inc. and Sodexo, Inc. in opt-out actions asserting antitrust claims against major U.S. pork producers.
  • In re: Cattle and Beef Antitrust Litigation – Lead counsel for ALDI Inc. and Sodexo, Inc. in opt-out actions asserting antitrust claims against major U.S. beef producers.
  • In re: Generic Pharmaceuticals Pricing Antitrust Litigation – Representing Sun Pharmaceuticals and Taro Pharmaceuticals in one of the largest-ever antitrust actions, which includes a consolidated multi-district litigation comprised of multiple classes and dozens of opt-out plaintiffs, multiple cases brought by state attorneys general, and additional separate actions brought in state courts.
  • In re: Shale Oil Antitrust Litigation – Representing EOG Resources, Inc. against antitrust class actions consolidated in multi-district litigation pending in the District of New Mexico.
  • Langston Patterson, et al. v. NCAA – Representing a putative class of NCAA Division I athletes in antitrust action proceeding in the Middle District of Tennessee challenging “redshirt” eligibility restrictions.
  • In re: Humira Antitrust Litigation – Represented a major pharmaceutical company in in antitrust litigation filed in the Northern District of Illinois, in which class plaintiffs alleged reverse-payment settlement agreements between the brand and biosimilar manufacturers; the litigation was dismissed in its entirety at the motion to dismiss stage, which was affirmed by the Seventh Circuit Court of Appeals.
  • Takeda Pharmaceutical Co., Ltd., et al. v. Zydus Pharmaceuticals (USA) Inc., et al. – Represented major generic pharmaceutical company in asserting antitrust counterclaims involving alleged sham litigation and misuse of Hatch-Waxman regulatory scheme.
  • Represented industrial manufacturer in a class action alleging a Section 1 price-fixing conspiracy; granted a favorable ruling on summary judgment, which was affirmed on appeal.
  • Represented healthcare manufacturers in a class action alleging a Section 1 price-fixing conspiracy; granted a favorable judgment on a motion to dismiss the original consolidated complaint.
  • Represented generic pharmaceutical manufacturers in Hatch-Waxman Act litigation; was deeply involved in negotiating settlements as well as in representing clients through trial.
  • Represented manufacturer in a civil action that initially asserted antitrust and various common law claims; the plaintiff voluntarily dismissed the antitrust claim rather than responding to a motion to dismiss directed to that claim.
  • Represented a mother and child in a pro bono action against a state department of family services, alleging violations of the mother's and child's constitutional rights; granted a six-figure monetary settlement for the mother and child, as well as extensive policy changes within the state department.

Awards and Community

Recognized as one of Lawdragon's "500 Leading Litigators in America," 2024, 2025 & 2026

Recognized as a "Rising Star" by The Legal 500 U.S., 2022 & 2023

Recognized as a Washington D.C. Super Lawyer-Rising Star (Thomson Reuters), 2022